Loading…
Paragon Fine and Speciality Chemical (PARAGON)₹46.15−3.85%Dyes And Pigments
In the Mar 2026 quarter (standalone), Paragon Fine and Speciality Chemical reported sales of ₹68.79 Cr, up 7.7% from Mar 2025, and net profit of ₹6.98 Cr, up 74.9% year on year. For the year to Mar 2026, sales were ₹110 Cr and net profit ₹8.98 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 71.84 | 59.85 | 60.77 | 51.81 | 63.86 | 40.89 | 68.79 |
| Expenses | 61.20 | 51.16 | 50.13 | 50.12 | 58.15 | 38.10 | 59.17 |
| Operating Profit | 10.03 | 9.02 | 11.04 | 2.01 | 6.02 | 3.01 | 10.04 |
| OPM % | 15.0% | 14.9% | 18.0% | 4.7% | 9.0% | 7.0% | 14.0% |
| Other Income | 0.00 | 0.00 | 1.01 | 1.01 | 0.00 | 0.00 | 1.01 |
| Interest | 0.99 | 0.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 1.01 | 1.01 | 1.01 | 1.01 |
| Profit before tax | 10.02 | 8.01 | 11.01 | 3.01 | 6.01 | 2.01 | 10.01 |
| Tax % | 28.0% | 26.0% | 26.1% | 33.0% | 27.1% | 20.0% | 27.1% |
| Net Profit | 6.99 | 5.99 | 7.98 | 1.99 | 3.99 | 1.99 | 6.98 |
| EPS (Rs) | 19.21 | 4.15 | 4.24 | 0.86 | 2.14 | 1.01 | 3.60 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 80.82 | 82.79 | 82.77 | 104 | 121 | 116 | 110 |
| Expenses | 77.21 | 77.28 | 77.20 | 89.29 | 102 | 108 | 97.28 |
| Operating Profit | 4.02 | 6.01 | 6.02 | 15.04 | 20.07 | 9.03 | 13.05 |
| OPM % | 4.8% | 8.0% | 7.0% | 14.0% | 16.0% | 7.0% | 12.0% |
| Other Income | 2.01 | 1.01 | 2.01 | 1.01 | 1.01 | 1.01 | 1.01 |
| Interest | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.00 | 0.00 |
| Depreciation | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 |
| Profit before tax | 4.01 | 6.01 | 6.01 | 14.02 | 19.02 | 8.01 | 12.02 |
| Tax % | 39.1% | 27.0% | 27.1% | 27.0% | 26.1% | 28.1% | 26.1% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | 1.99 | 3.99 | 3.99 | 9.98 | 13.96 | 5.98 | 8.98 |
| EPS (Rs) | 244.79 | 439.23 | 448.32 | 27.34 | 7.30 | 3.02 | 4.62 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.11 | 0.11 | 0.11 | 4.00 | 19.93 | 19.96 | 19.95 |
| Reserves | 3.01 | 7.99 | 11.99 | 18.96 | 63.80 | 69.89 | 78.79 |
| Borrowings | 11.98 | 21.95 | 20.96 | 24.93 | 8.97 | 2.99 | 0.99 |
| Other Liabilities | 21.90 | 19.90 | 23.88 | 23.89 | 12.93 | 10.95 | 8.96 |
| Total Liabilities | 37.90 | 49.85 | 57.84 | 70.78 | 106 | 104 | 108 |
| Fixed Assets | 5.99 | 6.99 | 9.99 | 8.99 | 10.98 | 15.99 | 18.96 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 2.99 | 3.99 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 31.91 | 42.86 | 47.85 | 61.79 | 93.66 | 84.81 | 85.74 |
| Inventories | 1.82 | 1.41 | 12.67 | 22.27 | 31.55 | 28.71 | 28.50 |
| Trade receivables | 21.30 | 29.53 | 21.58 | 27.12 | 25.52 | 39.34 | 42.56 |
| Cash & equivalents | 2.48 | 1.31 | 0.59 | 1.29 | 23.84 | 0.21 | 2.64 |
| Total Assets | 37.90 | 49.85 | 57.84 | 70.78 | 106 | 104 | 108 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from operating activity | 12.02 | −10.02 | 5.01 | −2.01 | 0.00 | −6.01 | 5.01 |
| Cash from investing activity | −0.99 | −0.99 | −3.99 | −0.99 | −17.97 | −1.99 | 0.00 |
| Cash from financing activity | −9.02 | 9.01 | −2.01 | 3.01 | 29.04 | −5.01 | −2.01 |
| Net cash flow | 1.99 | −0.99 | −0.99 | 0.99 | 11.99 | −12.99 | 1.99 |
| Capex | 0.55 | 2.15 | 4.02 | 0.79 | 3.00 | 8.77 | 4.93 |
| Free cash flow | 11.01 | −10.99 | 2.01 | −3.01 | −2.99 | −13.99 | 0.00 |
| CFO / OP % | 316.0% | −136.1% | 117.9% | −7.0% | 40.0% | −40.1% | 59.9% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor days | 97 | 131 | 96 | 96 | 78 | 125 | 142 |
| Inventory days | 11 | 10 | 84 | 113 | 139 | 125 | 139 |
| Days payable | 113 | 92 | 134 | 101 | 54 | 41 | 30 |
| Cash conversion cycle | −8 | 45 | 43 | 106 | 159 | 206 | 248 |
| Working capital days | 8 | 52 | 70 | 91 | 156 | 201 | 230 |
| ROCE % | — | 30.0% | 21.0% | 37.0% | 29.0% | 9.0% | 13.0% |
For the Mar 2026 quarter, Paragon Fine and Speciality Chemical reported sales of ₹68.79 Cr, up 7.7% year on year and net profit of ₹6.98 Cr, up 74.9% year on year. The operating margin was 14.0%.
Paragon Fine and Speciality Chemical's sales for the year to Mar 2026 were ₹110 Cr.
Net profit for the year to Mar 2026 was ₹8.98 Cr. Earnings per share over the same trailing period were ₹4.62.
Paragon Fine and Speciality Chemical reported borrowings of ₹0.99 Cr at Mar 2026, against cash and equivalents of ₹2.64 Cr.
Cash from operations was ₹5.01 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹0 Cr.